Endothelial Dysfunction in Obese Children Biochemistry Section Namrata ChhaBra, SahiBa KuKreja, Sahil ChhaBra, Sarah ChhaBra, KaviSh rameSSur that link obesity to endothelial dysfunction. Endothelial The magnitude of lifetime risk of cardiovascular disease dysfunction is a reversible disorder, pharmacological (CVD) has radically increased along with the high and non pharmacological interventions can reverse the prevalence of obesity in children. The risk factors emerge changes. Weight loss leads to an attenuation of the pro- quite early in the clinical course of obesity, which might inflammatory state and the physical exercise increases have important consequences for the development the synthesis and release of nitric oxide, which leads of atherosclerosis later in life. Endothelial dysfunction to augmented flow-mediated dilation and improvement represents a key early step in the development of in endothelial function. These changes are consistent atherosclerosis and is also involved in plaque progression with a decreased risk of atherosclerotic progression and and the occurrence of atherosclerotic complications. reduced risk of cardiovascular disease in obese children.
Endothelial changes are known to commence in Obesity is associated with both endothelial dysfunction childhood and are present in severely obese children. In and increased risk of CVD. Measurement of endothelial endothelial dysfunction, there is a reduction in the bio- dysfunction in children can predict the onset of availability of vasodilators whereas endothelial derived atherosclerosis. Non pharmacological and pharmacological contracting factors are increased; aside from that there interventions targeting obesity can improve clinical is a state of ‘Endothelial activation' that favors all stages cardiovascular outcomes in obese children.
of atherogenesis. Insulin resistance and the presence of a proinflammatory state are two likely mechanisms Keywords: Atherosclerosis, Cardiovascular disease (CVD), Endothelial dysfunction, Endothelial activation, Insulin resistance, Nitric oxide, Obesity alone. Several factors contribute to the obesity epidemic. The increasing prevalence of medically significant childhood The sustained excess of energy-dense foods, an increasingly obesity raises great concern. Childhood obesity has more sedentary lifestyle—attributed in part to urbanization, which than doubled in children and tripled in adolescents in the past limits the opportunities for physical activity, are the major 30 years [1]. In 2010, more than one third of children and causes of energy imbalance leading to childhood obesity. adolescents were overweight or obese [1].
The metabolic programming can occur as a result of in utero Although body mass index (BMI) >25 indicates overweight environmental exposures [7]. Small-for-gestational age babies and >30 defines obesity in adults, the diagnosis of overweight have an increased incidence of adverse health outcomes in children relies on age-adjusted percentiles [2]. The World later in life associated with insulin resistance, including type Health Organization and U.S. Centers for Disease Control and 2 diabetes, obesity, and cardiovascular disease. Some Prevention, each have definitions of overweight and obesity in instances of severe, early-onset, morbid obesity may result children and adolescents [Table/Fig-1]. At different ages, these from defects in genes encoding adipose-derived hormones criteria give somewhat different estimates of overweight and such as leptin, neuropeptides such as proopiomelanocortin, obesity prevalence [3-6]. The increased incidence of childhood cocaine- and amphetamine-regulated transcript (CART), and obesity cannot be blamed on either environment or genetics melanocortin-4, or the receptors for these ligands [8].
National Journal of Laboratory Medicine. 2015 Apr, Vol 4(2): 17-24 Namrata Chhabra et al., Endothelial Dysfunction in Obese Children Definition of Childhood Obesity World Health Organization WHO Child Growth Standards (birth to age 5) [3]
• Obese: Body mass index (BMI) > 3 standard deviations above the WHO growth standard median
• Overweight: BMI > 2 standard deviations above the WHO growth standard median
• Underweight: BMI < 2 standard deviations below the WHO growth standard median
WHO Reference 2007 (ages 5 to 19) [4]
• Obese: Body mass index (BMI) > 2 standard deviations above the WHO growth standard median
• Overweight: BMI > 1 standard deviation above the WHO growth standard median
• Underweight: BMI < 2 standard deviations below the WHO growth standard median
U.S. Centers for Disease Control CDC Growth Charts [5]
In children ages 2 to 19, BMI is assessed by age- and sex-specific percentiles:• Obese: BMI ? 95th percentile• Overweight: BMI ? 85th and < 95th percentile• Normal weight: BMI ? 5th and < 85th percentile• Underweight: BMI < 5th percentileIn children from birth to age 2, the CDC uses a modified version of the WHO criteria [6] [Table/Fig-1]: Childhood obesity definition [3-6]
Obesity is associated with an increase in mortality, with a 50–
100% increased risk of death mostly due to cardiovascular c) Endothelial dysfunction causes. Although the data in childhood are less exhaustive, d) Ischemic heart disease about 60% of overweight 5 to10-year-old children are reported e) Left ventricular hypertrophy to have at least one associated cardiovascular risk factor, f) Increased Carotid artery stiffness and 25% have 2 or more [9]. The important implications of childhood obesity [10] have been highlighted in [Table/Fig-2]. g) Increased carotid artery intima media thickness It has been recognized that the risk factors emerge quite early in the clinical course of obesity, which might have important a) Impaired glucose tolerance consequences for development of atherosclerosis later in life. b) Insulin resistance Increase in body mass index (BMI), an indicator of general c) Diabetes mellitus obesity, is often an independent risk factor for the development d) Metabolic syndrome of elevated blood pressure, clustering of various cardiovascular risk factors in metabolic syndrome, abnormal vascular wall thickness, endothelial dysfunction and left ventricular f) Early menarche hypertrophy [11]. Baker et al., reported the association between BMI in childhood (7 to 13 years of age) and coronary b) Obesity hypoventilation syndrome heart disease in adulthood (25 years or older) in a huge c) Bronchial asthma cohort of men and women in whom childhood BMI data were available [12]. The results of various studies have indicated a) Non alcoholic fatty liver disease that a deleterious alteration of endothelial physiology, also b) Cholelithiasis referred to as endothelial dysfunction, represents a key early step in the development of atherosclerosis and is also involved in plaque progression and the occurrence of atherosclerotic a) Poor self esteem complications [13]. Endothelial changes are known to commence in childhood [14,15] and are present in severely b) Distorted peer relationships obese children [15]. Diabetes mellitus, hypercholesterolemia, and arterial hypertension have all been shown to promote atherosclerosis by their cumulative effects on the vascular endothelium.
[Table/Fig-2]: The clustering of obesity induced cardiovascular risk
factors in childhood can explain the increased risk of adult coronary
heart disease [10] Endothelium is no more considered an inert lining of the blood vessels; it is actually a highly specialized, metabolically National Journal of Laboratory Medicine. 2015 Apr, Vol 4(2): 17-24 www.njlm.jcdr.net Namrata Chhabra et al., Endothelial Dysfunction in Obese Children examples of biomolecules ROLE OF NITRIC OXIDE
The most critical of the substances released by endothelium is nitric oxide (NO). Like other vasodilators, NO exerts its effect on the vascular smooth muscle by activating soluble guanylate cyclase to produce cyclic Guanosine monophosphate (cGMP), Endothelium-derived hyperpolarizing which is the intracellular second messenger of NO [17]. Shear stress and/or acetylcholine stimulate the release of NO from endothelial cells [18]. There is a well-established relationship between reactive oxygen species (ROS) and NO. NO has a direct effect on oxidative stress by scavenging ROS, and NO inactivation is enhanced in the presence of excess ROS [19].
Angiotensin II (AII) NO not only regulates vascular tone, it also has a key "antiatherogenic" role with the regulation of vascular permeability, the inhibition of platelet adhesion/aggregation, leukocyte/wall interaction, and smooth muscle proliferation [20]. These biologic actions of NO make it an important component in the endogenous defense against vascular Endothelin (ET-1) injury, inflammation, and thrombosis, which are all key events in the progression of atherosclerosis [21].
Platelet derived growth factor (PDGF) Basic fibroblast growth factor (PGF) Insulin-like growth factor – I (IGF-I) Endothelial dysfunction can be defined as, "the partial or complete loss of balance between vasoconstrictors and vasodilators, growth promoting and growth inhibiting factors, proatherogenic and anti-atherogenic factors" [22]. Growth Inhibitors Nitric oxide In endothelial dysfunction, there is reduction in the bio- Transforming growth factor I (TGFB) availability of vasodilators, in particular, nitric oxide (NO), whereas endothelial derived contracting factors are increased [23]. Endothelial dysfunction, aside from denoting impaired endothelium dependent vasodilatation, also comprises a specific state of ‘Endothelial activation' which is characterized Endothelial leukocyte adhesion molecule; by a pro-inflammatory, proliferative and procoagulatory milieu that favors all stages of atherogenesis [19]. It is thought that Intercellular adhesion molecule disruption of the functional integrity of the vascular endothelium Vascular cell adhesion molecule (VCAM) plays an integral role in all stages of atherogenesis ranging from lesion initiation to plaque rupture.
Tissue-type plasminogen activator Obesity is associated with both endothelial dysfunction and increased risk of CVD in adults; therefore it is hypothesized that Plasminogen activator inhibitor-1 (PAI-I) a similar relationship can be found between these variables in children. It is suggested that programming effects and the [Table/Fig-3]: The vascular homeostasis is maintained by
endothelium derived biomolecules [16]
classical cardiovascular risk factors such as obesity, impair the endothelial function from as early as the first decade of life [20]. Thus, measurement of endothelial dysfunction in children can predict the onset of atherosclerosis without the need to active interface between blood and the underlying tissues. follow to an age when clinical manifestations of CVD become The endothelium plays a vital role in vascular homeostasis, vascular tone regulation, vascular smooth cell proliferation, trans endothelial leukocyte migration, thrombosis and MECHANISM OF OBESITY INDUCED
thrombolytic balance. In response to various mechanical and chemical stimuli, endothelial cells synthesize and release a While the causes of endothelial dysfunction in obesity remain large number of vasoactive substances, growth modulators unclear and incompletely explored, insulin resistance and the and other factors that mediate these functions [16]. [Table/ presence of a proinflammatory state are two likely mechanisms Fig-3] depicts the details of the biomolecules release by linking obesity to endothelial dysfunction. Abnormalities in endothelium to maintain the vascular homeostasis [16].
LDL characteristics, increased activity of the renin–angiotensin system and elevated concentrations of non esterified fatty National Journal of Laboratory Medicine. 2015 Apr, Vol 4(2): 17-24 Namrata Chhabra et al., Endothelial Dysfunction in Obese Children acids (NEFA) have all been implicated. However, the most expression in vascular endothelial cells. In clinical studies in compelling evidences are for insulin resistance, an effect of adults, hypoadiponectinemia has been found to be directly inflammation and/or elevated leptin concentration on the correlated with endothelial function of the peripheral arteries endothelium [24].
Several factors including visceral adiposity, physical inactivity Leptin concentrations rise exponentially with increasing and genetic factors contribute to the development of insulin percentage body fat, and obese individuals have markedly resistance. Insulin resistance is associated with endothelial increased leptin production, probably as a consequence of dysfunction and insulin sensitivity is inversely proportional to resistance to its actions. However, the widespread distribution the development of atherosclerosis [25]. Petrie et al., showed of functioning leptin receptors on vascular cells and other cell a close positive relationship between insulin sensitivity and populations and on atherosclerotic lesions suggests that leptin basal endothelial NO production [26]. Winkler et al., showed also plays an important role in vascular physiology [28].
that increased levels of TNF-α may be one of the linking Taken together, the status of endothelial function represents factors in the insulin resistance and endothelial dysfunction an integrated index of both the overall cardiovascular risk relationship [27].
factor burden and the sum of all vasculoprotective factors As obesity is associated with features of acute-phase activation in any given individual [42]. The presence of endothelial and low-grade inflammation, elevated levels of inflammatory dysfunction can be regarded as a clinical syndrome that markers such as fibrinogen, C-reactive protein and IL-6 might per se is associated with and predicts an increased rate of also affect vascular dysfunction. Furthermore, adipose tissue adverse cardiovascular events [43].
produces cytokine-like molecules such as leptin and TNF-α, collectively termed adipokines that could affect vascular ASSESSMENT OF ENDOTHELIAL
function by their local and distant actions [28].
Various studies have shown that overweight children have A common approach to the evaluation of endothelial function higher CRP levels than normal weight children [29,30]. is the assessment of blood flow and vascular reactivity Fichtlscherer et al., showed that elevated CRP levels indicative since the first description of endothelial dysfunction in of a systemic inflammatory response reflected blunted atherosclerotic epicardial coronary arteries in 1986 by Ludmer et al., [44]. The consequences of an abnormal vasodilator systemic endothelial function and normalization of CRP levels response (i.e. impaired vasodilatation and even paradoxical over time were associated with a significant improvement in vasoconstriction of coronary arteries upon the administration endothelium-mediated blood flow responses [31].
of acetylcholine) have thereafter been extensively studied. IL-6 is a proinflammatory, endocrine cytokine that stimulates Epicardial and microvascular coronary endothelial dysfunction the production of acute-phase proteins, including CRP [29]. predicts CV events in patients with and without coronary Within adipose tissue, both adipocytes and macrophages artery disease [45]. Measurement of flow-mediated dilation secrete IL-6, with roughly 30 percent of total production (FMD) at the level of a large conduit artery, usually the brachial being initiated in the adipose tissue [32]. Production of IL-6 artery, has since then become the most applied technique by adipose tissue increases with increasing adiposity, and [46]. Typically, ischemia is induced in the forearm or hand circulating IL-6 concentrations are highly correlated with both using a tourniquet inflated to above systolic pressure. Release percent body fat [33] and insulin resistance [34].
of the tourniquet causes reactive hyperemia, an increase in TNF-α, a proinflammatory cytokine has been shown to induce blood flow through the brachial artery, and hence a release of NO. The resulting vasodilation is measured by continuous an impairment of endothelium-dependent vasodilatation in a high-resolution ultrasound and the maximum vasodilation is variety of vascular beds by increasing oxidative stress and expressed as a percentage of the baseline brachial arterial decreasing the release of NO [35]. TNF-α has a major role in diameter [47]. Peripheral arterial tonometry was developed adipose tissue and there is evidence of a three-fold increase in as a novel technique to overcome the disadvantages of TNF-α mRNA protein and circulating levels in obese individuals user dependence of FMD. Invasive assessment of coronary [36]. Within adipose tissue, macrophages account for nearly endothelial function by quantitative coronary angiography all TNF-α production [32] and increased TNF- α expression and coronary Doppler flow measurements, along with graded has also been linked to the development of insulin resistance intracoronary infusions of endothelium dependent vasodilators such as acetylcholine were considered the ‘Gold standard' for In an obese state, plasma concentrations of adiponectin endothelial function testing [47] but the invasive characters are decreased [37]. Adiponectin plays an important role in prohibit their use in healthy individuals and children.
the regulation of insulin action, and has been shown to be Another approach is to measure levels of the members of negatively correlated with insulin resistance [38]. In addition endothelial activation, such as soluble vascular cell adhesion to its effect on glucose metabolism, adiponectin appears to molecule (VCAM), soluble intracellular adhesion molecules modulate endothelial function. Adiponectin has been shown to (ICAM), Endothelin-I (ET-I) and other markers of coagulation stimulate production of NO and suppress adhesion molecule and fibrinolysis such as PAI-I, Tissue plasminogen activator National Journal of Laboratory Medicine. 2015 Apr, Vol 4(2): 17-24 www.njlm.jcdr.net Namrata Chhabra et al., Endothelial Dysfunction in Obese Children or Von-Willebrand factors (VWP) and markers of low grade The pathological vasoreactivity in obesity is a complex inflammation such as C-reactive proteins, IL-I, IL-6, and TNF- multifactorial phenomenon. Increased serum levels of vasoconstrictive prostaglandins, proinflammatory cytokines, The identification and quantification of circulating endothelial and adiponectin and changes in lipoproteins (elevated serum cells (CECs) has evolved as a novel marker of endothelial LDL and chylomicron remnants, lowered HDL) have all been function. CECs appear to be a different population of cells to implicated in its pathogenesis [2].
endothelial progenitor cells [48]. As a technique, it correlates Although the mechanisms by which diet alone improves with other markers of endothelial function such as flow- endothelial function remain far from being fully understood, mediated dilation, the measurement of von Willebrand factor, evidence is accumulating that a combined reduction of and tissue plasminogen activator. Quantification of CECs is LDL and other atherogenic lipoproteins, reduced rate of difficult due to low numbers, variable morphology, and a lack hyperglycemia, and lower oxidative stress are involved [59].
of standardization in current techniques used. A combination of diet and exercise leads to a better MANAGEMENT OF ENDOTHELIAL
improvement of endothelial function as contrast to diet alone [60]. Although results from several randomized controlled trials DYSFUNCTION IN OBESE CHILDREN
with dietary components are quite promising, effects need to Endothelial dysfunction is a reversible disorder, pharmacological be confirmed in larger population-based studies.
and non pharmacological interventions can reverse the Orlistat, a reversible blocker of lipase, is the only drug available Non pharmacological Interventions
to help weight loss. A meta-analysis of available data in children a) Weight management- Weight loss leads to an improvement
stated that the drug caused 5kg weight loss and 5cm reduction of CV risk factors associated with endothelial dysfunction in in waist circumference after at least 6 months of therapy childhood obesity [49]. Weight loss leads to a reduction in the compared with placebo, but failed to improve dyslipidemia and plasma levels of various adipocytokines, to an attenuation of insulin levels [61]. Rimonabant and sibutramine, the other two the pro-inflammatory state, and to improvement in endothelial drugs due the increased risk of psychiatric adverse events [62] function [50].
and increased CV risk [63], respectively, have been withdrawn b) Physical exercise- The increase in blood flow and shear from the international market. Metformin significantly improves stress that accompanies regular aerobic exercise elicits an both endothelial function and insulin resistance in adults with adaptive response that alters the intrinsic responsiveness of metabolic syndrome [64] but the results are less satisfactory the endothelium by increasing mRNA expression of eNOS. in children [65].
This in turn increases the synthesis and release of NO which Given that increased oxidative stress plays a pivotal role in leads to augmented flow-mediated dilation and ultimately the pathogenesis of endothelial dysfunction, administration of improves endothelial function [51].
antioxidants would be expected to be a reasonable strategy to On top of increasing NO synthesis, exercise decreases treat this disorder. Supplementation with antioxidants such as production of ROS by reducing Nicotinamide Adenine Glutathione, N-acetyl cysteine, and vitamin C has been shown Dinucleotide Phosphate (NAD (P) H) oxidase activity [52] and by to reverse endothelial dysfunction in coronary and peripheral enhancement of antioxidant capacity [53]. Other contributing arteries [66]. LDL reduction by either diet or statin therapy mechanisms might include improvements in insulin sensitivity, has been related to improved endothelial function in previous proinflammatory cytokines, and/or lipoprotein profiles [54].
intervention studies [59,67]. Although statin therapy has been Watts et al., [55] reported that FMD was impaired in obese effectively used to normalize endothelial dysfunction in children children, and the exercise was successful in improving with familial hypercholesterolemia,[68] the consensus is that the impairment. As little as eight weeks of exercise training pharmacological interventions should not be the first choice consisting of three 1-hour sessions of circuit training each to treat alimentary-induced hyperlipidemia and endothelial week led to a significant improvement in endothelial function, dysfunction in obesity [2].
even without weight loss in a randomized cross-over study The treatment of obesity remains difficult. Certain effective drug [55,56]. Two other studies, one involving endurance training therapies have been withdrawn from the market because of and another applying aerobic interval training, confirmed the dangerous cardiovascular effects, [69]. Nonpharmacological effect of exercise alone on endothelial function [56,57] interventions such as low- calorie diet and physical exercise c) Dietary Interventions- It is not obesity itself that causes
therefore represent the mainstays of obesity prevention and endothelial dysfunction but rather the hypercaloric high-fat diet that precedes the weight gain [2]. In obese adults (BMI 35±5), a low-calorie diet can significantly enhance flow-mediated brachial artery vasodilation by 60% and reduce body weight Endothelial dysfunction is significantly associated with obesity by 11% [58].
in otherwise healthy, non-hypertensive and pre-pubertal children. Prevention of obesity or early management of National Journal of Laboratory Medicine. 2015 Apr, Vol 4(2): 17-24 Namrata Chhabra et al., Endothelial Dysfunction in Obese Children obesity can abate or reverse almost all of the cardiovascular dysfunction in children and adults at risk of atherosclerosis. consequences of obesity. Further studies are needed to Lancet. 1992; 340: 1111–15.
identify surrogate markers of endothelial dysfunction to best [14] Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular assess, predict, and treat the children who are vulnerable to risk factors and atherosclerosis in children and young adults. The developing CVD.
Bogalusa Heart Study. N Engl J Med. 1998; 338(23):1650-56.
[15] Tounian P, Aggoun Y, Dubern B, Varille V, Guy-Grand B, Sidi D, et al. Presence of increased stiffness of the common carotid We are sincerely grateful to Dr. (Professor) A.K .Lavania for his artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 2001; 358:1400-04.
unconditional support and valuable guidance.
[16] Chhabra N. Endothelial dysfunction – A predictor of atherosclerosis. Internet Journal of Medical Update 2009; BMI (Body mass index; CVD (cardiovascular disease) ; [17] Niebauer J, Cooke JP. Cardiovascular Effects of Exercise: Role CV(cardiovascular); NO(nitric oxide); ROS (reactive oxygen of Endothelial Shear Stress. J Am Coll Cardiol. 1996; 28:1652-60.
species); NEFA(non esterified fatty acids) ; LDL(low density [18] Gielen S, Erbs S, Schuler G, Hambrecht R. Exercise Training and lipoprotein); CRP(c- reactive protein); IL-6 (interleukin-6); Endothelial Dysfunction in Coronary Artery Disease and Chronic TNF-α(tumor necrosis factor-alpha); mRNA(messenger Heart Failure. Minerva Cardioangil. 2002; 50:95-109.
RNA); VCAM (vascular cell adhesion molecules); VWP ( Von- [19] Williams IL, Wheatcroft SB, Shah AM, Kearney MT. Obesity, Willebrand factors); PAI (plasminogen activator inhibitor).
Atherosclerosis and the Vascular Endothelium: Mechanisms of Reduced Nitric Oxide Bioavailability in Obese Humans. Intern J Obesity. 2002; 26:754-64.
[20] Cooke JP, Tsao PS. Is NO an Endogenous Antiatherogenic [1] Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of Molecule? Arterioscler Thromb Vasc Biol. 1994; 14(5): 653-55.
obesity and trends in body mass index among US children and [21] Behrendt D, Ganz D. Endothelial Function: From Vascular Biology adolescents, 1999-2010. JAMA. 2012; 307(5):483-90. to Clinical Applications. Am J Cardio. 2002; 90: 40-48.
[2] Gielen S, Hambrecht R. The childhood obesity epidemic: impact [22] Quyyumi AA, Dakak N, Andrews NP, et al. Contribution of nitric on endothelial function. Circulation. 2004 Apr; 109(16):1911- oxide to metabolic coronary vasodilation in the human heart. Circulation. 1995; 92(3):320-26.
[3] de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, [23] Lerman A, Burnett JC Jr. Intact and altered endothelium in Siekmann J. Development of a WHO growth reference for regulation of vasomotion. Circulation. 1992; 86(6 Suppl): III 12-19.
school-aged children and adolescents. Bull World Health Organ. [24] Singhal A. Endothelial dysfunction: role in obesity-related disorders and the early origins of CVD. Proceedings of the [4] World Health Organization. World Health Organization Child Nutrition Society. 2005; 64(1): 15 - 22.
Growth Standards. 2006. Accessed March 5,2012.
[25] Anderson TJ. Assessment and treatment of endothelial [5] Kuczmarski R, Ogden CL, Grummer-Strawn LM, et al. CDC dysfunction in humans. J Am Coll Cardiol. 1999; 34(3):631-38. Growth Charts: United States. Hyattsville, MD: National Center [26] Petrie JR, Ueda S, Webb DJ, Elliott HL, Connell JM. Endothelial for Health Statistics; 2000.
nitric oxide production and insulin sensitivity. A physiological link [6] Grummer-Strawn LM, Reinold C, Krebs NF. Use of World Health with implications for pathogenesis of cardiovascular disease. Organization and CDC growth charts for children aged 0-59 Circulation. 1996; 93:1331-33. months in the United States. MMWR Recomm Rep. 2010;59:1- [27] Winkler G, Lakatos P, Salamon F, Nagy Z, Speer G, Kovács M, et al. Elevated serum TNF-alpha level as a link between [7] Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes endothelial dysfunction and insulin resistance in normotensive mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992; obese patients. Diabet Med. 1999; 16(3):207–11.
[28] Gielen S, Erbs S, Schuler G, Hambrecht R. Exercise Training and [8] Rajala MW, Scherer PE. Mini review: The adipocyte-at Endothelial Dysfunction in Coronary Artery Disease and Chronic the crossroads of energy homeostasis, inflammation, and Heart Failure. Minerva Cardioangil. 2002; 50:95-109. atherosclerosis. Endocrinology. 2003; 144(9):3765–73.
[29] Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Low- [9] Jeffrey P. Koplan, William H. Dietz. Caloric imbalance and public grade Systemic Inflammation in Overweight Children. Pediatrics. health policy. JAMA. 1999; 282(16):1579-81. 2001; 107(1): E13.
[10] National Institutes of Health, National Heart, Lung, and Blood [30] Ford ES. C-reactive Protein Concentration and Cardiovascular Disease Risk Factors in Children: Findings from the National Institute. Disease and Conditions Index: What Are Overweight Health and Nutrition Examination Survey. 1999-2000. Circulation. and Obesity? Bethesda, MD: National Institutes of Health. 2003; 108:1053-58.
[31] Fitchtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler [11] Fei Ho T. Cardiovascular Risks Associated With Obesity in S. Elevated C-reactive Protein Levels and Impaired Endothelial Children and Adolescents. Ann Acad Med Singapore. 2009; Vasoreactivity in Patients with Coronary Artery Disease. Circulation. 2000; 102:1000-06.
[12] Baker JL, Olsen LW, Sorensen TI. Childhood body mass index [32] Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, and the risk of coronary heart disease in adulthood. N Engl J Ferranti AW. Obesity is Associated with Macrophage Accumulation Med. 2007; 357(23):2329—37.
in Adipose Tissue. J Clin Invest. 2003; 112(12):1796-1808.
[13] Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, [33] Fried SK, Bunkin DA, Greenberg AS. Omental and Subcutaneous Miller OI, Sullivan ID et al. Non-invasive detection of endothelial Adipose Tissues of Obese Subjects Release Interleukin-6: Depot National Journal of Laboratory Medicine. 2015 Apr, Vol 4(2): 17-24 www.njlm.jcdr.net Namrata Chhabra et al., Endothelial Dysfunction in Obese Children Difference and Regulation by Glucocorticoid. J Clin Endocrinol [50] Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi Metab. 1998; 83:847-50.
M, et al. Reduction of inflammatory cytokine concentrations [34] Bastard JP, Jardel C, Bruckert E, Blondy P, Chapeau J, Laville and improvement of endothelial function in obese women after M. et al. Elevated Levels of Interleukin-6 Are Reduced in Serum weight loss over one year. Circulation. 2002; 105(7): 804–09.
Subcutaneous Adipose Tissue of Obese Women After Weight [51] Moyna NM, Moyna PD. The effect of Physical Activity on Loss. J Clin Endocrinol Metab. 2000; 85: 3338-42.
Endothelial Function in Man. Acta Physiol Scand. 2004;180:113- [35] Turner RC, Millins H, Neil HA, Stratton IM, Manley SE, Matthews DRm Holman RR. Risk Factors for Coronary Artery Disease [52] Adams V, Linke A, Kränkel N, Erbs S, Gielen S, Möbius-Winkler S in Non-insulin Dependent Diabetes Mellitus: United Kingdom et al. Impact of regular physical activity on the NAD (P) H oxidase Prospective Diabetes Study. BMJ. 1998; 316:823-28. and angiotensin receptor system in patients with coronary artery [36] Winkler G, Lakatos P, Salomon F, Nagy Z, Speer G, Kovács M, disease. Circulation. 2005; 111(5):555-62.
et al. Elevated Serum TNF-alpha as a Link Between Endothelial [53] G. S. L. Ferrari and C. K. B. Ferrari, Exercise modulation of total Dysfunction and Insulin Resistance in Normotensive Obese antioxidant capacity (TAC): towards a molecular signature of Patients. Diab Med. 1999; 16(3):207-11.
healthy aging, Frontiers in Life Science. 2011;5(3-4):81–90. [37] Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa [54] Yudkin JS, Stehouwer CDA, Emeis JJ, et al. C-reactive protein J. et al. Paradoxical Decrease of an Adipose-Specific Protein, in healthy subjects: Associations with obesity, insulin resistance, Adiponectin, in Obesity. Biochem Biophys Res Commun. 1999; and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. [38] Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, et al. Plasma adiponectin concentrations predict insulin [55] Watts K, Beye P, Siafarikas A, Davis EA, Jones TW, O ‘Driscoll sensitivity of both glucose and lipid metabolism. Diabetes 2003; G, et al. Effects of exercise training on vascular function in obese children. J Pediatr. 2004; 144:620–25.
[39] Tan KC, Xu A, Chow WS, Lam MC, Ai VH, Tam SC, et al. [56] K Watts, P Beye, A Siafarikas, et al., Exercise training normalizes Hypoadiponectimia is associated with impaired endothelium- vascular dysfunction and improves central adiposity in obese dependent vasodilation. J Clin Endocrinol Metab. 2004; adolescents, Journal of the American College of Cardiology. 2004;43(10):1823–27. [40] Shimabukuro M, Higa N, Asahi T, Oshiro Y, Takasu N, Tagawa [57] AA Meyer, G Kundt, U Lenschow, P Schuff-Werner, and W Kienast, T et al. Hypoadiponectinemia is closely linked to endothelial Improvement of early vascular changes and cardiovascular risk dysfunction in man. J Clin Endocrinol Metab. 2003; 88:3236- factors in obese children after a six-month exercise program. Journal of the American College of Cardiology. 2006;48(9): 1865–70. [41] Ouchi N, Ohishi M, Kihara S, Funahashi T, Nakamura T, [58] AE Tjønna, TO Stølen, A Bye, et al. Aerobic interval training Nagaretani H, et al. Association of hypoadiponectinemia with reduces cardiovascular risk factors more than a multitreatment impaired vasoreactivity. Hypertension. 2003; 42:231-34.
approach in overweight adolescents. Clinical Science. [42] Deedwania PC. Endothelium: a new target for cardiovascular therapeutics. J Am Coll Cardiol. 2000; 35(1):67-70.
[59] Woo KS, Chook P, Yu CW, Sung RY, Qiao M, Leung SS, et [43] Zeiher AM, Drexler H, Wollschlager H, Just H. Endothelial al. Effects of diet and exercise on obesity-related vascular dysfunction of the coronary microvasculature is associated dysfunction in children. Circulation. 2004; 109:1981-86.
with coronary blood flow regulation in patients with early [60] Raitakari M, Ilvonen T, Ahotupa M, Lehtimäki T, Harmoinen A, atherosclerosis. Circulation. 1991; 84:1984–92.
Suominen P, et al. Weight reduction with very-low-caloric diet [44] Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, and endothelial function in overweight adults: role of plasma Alexander RW, et al. Paradoxical vasoconstriction induced by glucose. Arterioscler Thromb Vasc Biol. 2004; 24: 124–28.
acetylcholine in atherosclerotic coronary arteries. N Engl J Med. [61] Czernichow S, Lee CM, Barzi F, Greenfield JR, Baur LA, Chalmers J, et al. Efficacy of weight loss drugs on obesity [45] Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, and cardiovascular risk factors in obese adolescents: a meta- Waclawiw MA, et al. Prognostic value of coronary vascular analysis of randomized controlled trials. Obesity Reviews. 2010; endothelial dysfunction. Circulation. 2002; 106(6):653-58.
[46] Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield [62] Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A.: J, Ganz P, et al. The assessment of endothelial function: from Efficacy and safety of the weight-loss drug rimonabant: a meta- research into clinical practice. Circulation. 2012; 126(6): 753– analysis of randomized trials. Lancet. 2007; 370:1706–13.
[63] WPT James, ID Caterson, W Coutinho, Finer N, Luc F, Gaal [47] Hasdai D, Lerman AT. The assessment of endothelial function V, et al. Effect of sibutramine on cardiovascular outcomes in in the cardiac catheterization laboratory in patients with risk overweight and obese subjects. The New England Journal of factors for atherosclerotic coronary artery disease. Herz. 1999; Medicine. 2010; 363(10) : 905–917. [64] C. Vitale, G. Mercuro, A. Cornoldi, M. Fini, M. Volterrani, and [48] Paterick TE, Fletcher GF. Endothelial function and cardiovascular G. M. C. Rosano. Metformin improves endothelial function in prevention: role of blood lipids, exercise, and other risk factors. patients with metabolic syndrome. Journal of Internal Medicine Cardiol Rev. 2001; 9(5):282-86.
2005; 258(3):250–56. [49] SB Sondike, N. Cooperman. S. Jacobson. Effects of a low- [65] Clarson CL, Mahmud FH, Baker JE, Clark HE, McKay WM, carbohydrate diet on weight loss and cardiovascular risk factors Schauteet VD, et al. Metformin in combination with structured in overweight adolescents, Journal of Pediatrics 2003; vol.14 (3): lifestyle intervention improved body mass index in obese adolescents, but did not improve insulin resistance. Endocrine 2009; 36:141-46.
National Journal of Laboratory Medicine. 2015 Apr, Vol 4(2): 17-24 Namrata Chhabra et al., Endothelial Dysfunction in Obese Children [66] Carr A, Frei B. The role of natural antioxidants in preserving the [68] de Jongh S, Lilien MR, op't Roodt J, et al. Early statin biological activity of endothelium-derived nitric oxide. Free radic therapy restores endothelial function in children with familial Biol Med. 2000; 28(12):1806-14.
hypercholesterolemia. J Am Coll Cardiol. 2002; 40: 2117–21.
[67] Perticone F, Ceravolo R, Maio R, et al. Effects of atorvastatin [69] Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease and vitamin C on endothelial function of hypercholesterolemic associated with fenfluramine-phentermine. N Engl J Med. 1997; patients. Atherosclerosis. 2000; 152: 511–18.
337: 581–88.
5. Department of Biochemistry, S.S.R. Medical College, 1. Dr. Namrata Chhabra 2. Dr. Sahiba Kukreja 3. Dr. Sahil Chhabra Name, aDDreSS, e-mail iD OF the 4. Dr. Sarah Chhabra COrreSPONDiNG authOr: 5. Dr. Kavish Ramessur Dr. Namrata Chhabra, 5, Loretto Convent Street, Curepipe, Mauritius PartiCularS OF CONtriButOrS: E-mail : namarta28@gmail.com 1. Professor and Head, Department of Biochemistry, S.S.R. Medical College, Mauritius FiNaNCial Or Other COmPetiNG iNtereStS: 2. Professor and Head, Department of Biochemistry, Sri Guru Ram Das Medical College and Research Institute, Amritsar, Punjab, India 3. Department of Perioperative Medicine and Anesthesiology, University of Louisville, Louisville, Kentucky, USA.
4. Department of Biochemistry, S.S.R. Medical College, Date of Publishing: apr 01, 2015 National Journal of Laboratory Medicine. 2015 Apr, Vol 4(2): 17-24

Source: http://www.njlm.net/articles/PDF/2035/5-%2010696_CE(AJ)_F(Sh)_PF1(PAK)_PFA(AK).pdf

Antidepressants for smoking cessation

Antidepressants for smoking cessation (Review) Hughes JR, Stead LF, Lancaster T This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library2011, Issue 8 Antidepressants for smoking cessation (Review)Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Maintaining optimal health-cover-2010

AM P: SLTOPHO Acknowledgments The content of this booklet was researched and written by Dr. Janet McKeown (MD, CCFP, DipSportsMed), Cristina Sutter (Registered Sport Dietitian) and Susan Boegman (Registered Sport Dietitian) with input from Dr. Penny Miller (Clinical Pharmacologist), Dr. Susan Hollenberg (Family & Travel Medicine Physician), and Dr. Reka Gustafson (Medical Health Officer).